Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a sodium valproate study in adults with McArdle disease
2014-001637-88Phase 2Completed
- Sponsor
- John Vissing
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in glycogen storage disease type V (GSDV), sponsored by John Vissing. Primary endpoint: Exercise endurance on cycle ergometer. Started Jun 2014; status: completed.
02
Drugs
valproic acid
03
Conditions
glycogen storage disease type V (GSDV)
Beyond the preview
Go deeper on 2014-001637-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001637-88.